Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites with the Highest Rates within Race- and Ethnic-Specific Categories (Table 4.1.F1)*† Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
Text Description
Top 10 Cancer Sites: 2011, Female, United States *†
Rates per 100,000 ‡
| All Races | White | Black | Asian/Pacific Islander § | American Indian/Alaska Native § | Hispanic §|| | |
|---|---|---|---|---|---|---|
| 1 | Female Breast 122.0 |
Female Breast 122.8 |
Female Breast 121.2 |
Female Breast 87.8 |
Female Breast 69.6 |
Female Breast 92.1 |
| 2 | Lung and Bronchus 52.0 |
Lung and Bronchus 53.6 |
Lung and Bronchus 48.2 |
Colon and Rectum 27.8 |
Lung and Bronchus 38.4 |
Colon and Rectum 29.3 |
| 3 | Colon and Rectum 34.9 |
Colon and Rectum 33.9 |
Colon and Rectum 40.9 |
Lung and Bronchus 26.9 |
Colon and Rectum 25.5 |
Lung and Bronchus 24.9 |
| 4 | Corpus and Uterus, NOS 25.4 |
Corpus and Uterus, NOS 25.7 |
Corpus and Uterus, NOS 24.6 |
Thyroid 20.4 |
Corpus and Uterus, NOS 14.7 |
Corpus and Uterus, NOS 21.8 |
| 5 | Thyroid 20.5 |
Thyroid 21.5 |
Pancreas 14.4 |
Corpus and Uterus, NOS 17.3 |
Kidney and Renal Pelvis 12.1 |
Thyroid 19.1 |
| 6 | Melanomas of the Skin 15.6 |
Melanomas of the Skin 17.8 |
Thyroid 13.4 |
Non-Hodgkin Lymphoma 11.0 |
Non-Hodgkin Lymphoma 9.1 |
Non-Hodgkin Lymphoma 14.6 |
| 7 | Non-Hodgkin Lymphoma 15.5 |
Non-Hodgkin Lymphoma 15.9 |
Kidney and Renal Pelvis 12.6 |
Ovary 8.9 |
Thyroid 8.9 |
Kidney and Renal Pelvis 11.8 |
| 8 | Ovary 11.3 |
Ovary 11.7 |
Non-Hodgkin Lymphoma 11.3 |
Pancreas 8.4 |
Ovary 7.9 |
Ovary 10.1 |
| 9 | Kidney and Renal Pelvis 11.0 |
Kidney and Renal Pelvis 11.1 |
Myeloma 10.6 |
Stomach 7.4 |
Liver and Intrahepatic Bile Duct 6.5 |
Pancreas 10.0 |
| 10 | Pancreas 10.7 |
Leukemias 10.4 |
Cervix 9.0 |
Liver and Intrahepatic Bile Duct 7.2 |
Pancreas 6.3 |
Cervix 9.8 |
(Table 4.1.F1) Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites with the Highest Rates within Race- and Ethnic-Specific Categories
Footnotes
* Data are from selected statewide and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See registry-specific data qualityinformation. Rates cover approximately 99% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130).
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
|| Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
~ Rates are suppressed and not ranked if case counts are fewer than 16 or if the population of the specific category (race, ethnicity) is less than 50,000.
Confidence interval (CI): Range of values for a rate that will include the true value of the rate a given percentage of the time. Example: 95% CI includes the true value of the rate 95% of the time.
Notes: ONS – Other Nervous System; NOS – Not Otherwise Specified; IBD – Intrahepatic Bile Duct. Urinary bladder cases include invasive and in situ
Glossary
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014.
Comments